Cheviot Value Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.11M Sell
28,080
-37
-0.1% -$8.21K 0.61% 34
2025
Q4
$6.15M Sell
28,117
-427
-1% -$97.3K 0.6% 31
2025
Q3
$6.49M Sell
28,544
-293
-1% -$59.7K 0.69% 29
2025
Q2
$5.71M Sell
28,837
-260
-0.9% -$48.3K 0.65% 31
2025
Q1
$5.7M Sell
29,097
-960
-3% -$187K 0.7% 28
2024
Q4
$5.34M Sell
30,057
-37
-0.1% -$6.8K 1.02% 25
2024
Q3
$5.94M Sell
30,094
-1,173
-4% -$219K 1.12% 24
2024
Q2
$5.36M Sell
31,267
-607
-2% -$101K 1.05% 25
2024
Q1
$5.8M Sell
31,874
-503
-2% -$86.7K 1.27% 21
2023
Q4
$5.12M Sell
32,377
-2,031
-6% -$296K 1.1% 26
2023
Q3
$5.13M Sell
34,408
-245
-0.7% -$36K 1.14% 24
2023
Q2
$4.67M Buy
34,653
+762
+2% +$112K 1.02% 26
2023
Q1
$5.4M Sell
33,891
-388
-1% -$59.3K 1.3% 22
2022
Q4
$5.65M Sell
34,279
-19
-0.1% -$2.91K 1.39% 22
2022
Q3
$4.6M Sell
34,298
-367
-1% -$52.7K 1.26% 25
2022
Q2
$5.31M Sell
34,665
-135
-0.4% -$20.6K 1.32% 24
2022
Q1
$5.64M Buy
34,800
+2,099
+6% +$305K 1.19% 26
2021
Q4
$4.43M Sell
32,701
-182
-0.6% -$21.5K 1.04% 28
2021
Q3
$3.55M Sell
32,883
-27
-0.1% -$3.08K 0.91% 30
2021
Q2
$3.71M Sell
32,910
-308
-0.9% -$34.7K 0.91% 31
2021
Q1
$3.6M Buy
33,218
+2,217
+7% +$237K 1% 27
2020
Q4
$3.32M Buy
31,001
+971
+3% +$93.3K 1% 30
2020
Q3
$2.63M Sell
30,030
-90
-0.3% -$8.47K 0.91% 28
2020
Q2
$2.96M Sell
30,120
-865
-3% -$76.2K 1.15% 24
2020
Q1
$2.36M Sell
30,985
-778
-2% -$66.3K 1.08% 27
2019
Q4
$2.81M Sell
31,763
-708
-2% -$58.8K 1.08% 28
2019
Q3
$2.46M Sell
32,471
-185
-0.6% -$12.7K 1.05% 28
2019
Q2
$2.38M Sell
32,656
-103
-0.3% -$8.1K 1.03% 29
2019
Q1
$2.64M Sell
32,759
-716
-2% -$58.6K 1.28% 28
2018
Q4
$3.09M Sell
33,475
-10,070
-23% -$886K 1.61% 20
2018
Q3
$4.12M Sell
43,545
-1,699
-4% -$161K 1.93% 16
2018
Q2
$4.19M Sell
45,244
-1,696
-4% -$166K 2.05% 17
2018
Q1
$4.44M Sell
46,940
-8,878
-16% -$975K 2.31% 12
2017
Q4
$5.4M Sell
55,818
-5,054
-8% -$476K 2.8% 10
2017
Q3
$5.41M Sell
60,872
-1,095
-2% -$83.4K 2.94% 10
2017
Q2
$4.49M Sell
61,967
-8,584
-12% -$577K 2.62% 12
2017
Q1
$4.6M Sell
70,551
-682
-1% -$42.9K 2.59% 13
2016
Q4
$4.46M Buy
71,233
+86
+0.1% +$5.25K 2.67% 12
2016
Q3
$4.49M Sell
71,147
-1,921
-3% -$124K 2.79% 12
2016
Q2
$4.52M Sell
73,068
-699
-0.9% -$42.6K 2.7% 13
2016
Q1
$4.21M Sell
73,767
-584
-0.8% -$32.5K 2.69% 12
2015
Q4
$4.41M Sell
74,351
-570
-0.8% -$32.8K 2.85% 13
2015
Q3
$4.08M Sell
74,921
-1,664
-2% -$108K 2.71% 13
2015
Q2
$5.15M Sell
76,585
-311
-0.4% -$20.3K 3.04% 13
2015
Q1
$4.5M Buy
76,896
+1,073
+1% +$64.8K 2.65% 13
2014
Q4
$4.96M Sell
75,823
-2,453
-3% -$155K 2.89% 13
2014
Q3
$4.52M Sell
78,276
-3,618
-4% -$201K 2.62% 13
2014
Q2
$4.62M Sell
81,894
-12,393
-13% -$650K 2.47% 14
2014
Q1
$4.85M Sell
94,287
-6,346
-6% -$321K 2.67% 13
2013
Q4
$5.31M Sell
100,633
-3,120
-3% -$153K 2.93% 13
2013
Q3
$4.64M Sell
103,753
-4,547
-4% -$202K 2.56% 14
2013
Q2
$4.48M Buy
+108,300
New +$4.74M 2.44% 13

Other funds holding ABBV

Cheviot Value Management's ABBV Position: Q1 2026 in Review

Cheviot Value Management reduced its AbbVie (ABBV) stake by 0.13% in Q1 2026, selling an estimated $8.21K and leaving 28,080 shares worth $6.11M. The position accounts for 0.61% of the portfolio, ranked #34.

Cheviot Value Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.49M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Cheviot Value Management held 28,080 shares of AbbVie worth $6.11M as of Q1 2026.
  • Cheviot Value Management sold 37 AbbVie shares in Q1 2026, an estimated $8.21K.
  • AbbVie made up 0.61% of Cheviot Value Management's portfolio in Q1 2026, its #34 holding.
  • Cheviot Value Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Cheviot Value Management's AbbVie position peaked at $6.49M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Cheviot Value Management's 13F filing for Q1 2026, filed 12 May 2026.